Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,102 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease.
Koury MJ, Agarwal R, Chertow GM, Eckardt KU, Fishbane S, Ganz T, Haase VH, Hanudel MR, Parfrey PS, Pergola PE, Roy-Chaudhury P, Tumlin JA, Anders R, Farag YMK, Luo W, Minga T, Solinsky C, Vargo DL, Winkelmayer WC. Koury MJ, et al. Among authors: agarwal r. Am J Hematol. 2022 Sep;97(9):1178-1188. doi: 10.1002/ajh.26644. Epub 2022 Jul 15. Am J Hematol. 2022. PMID: 35751858 Free PMC article.
The role of statins in chronic kidney disease.
Agarwal R, Curley TM. Agarwal R, et al. Am J Med Sci. 2005 Aug;330(2):69-81. doi: 10.1097/00000441-200508000-00004. Am J Med Sci. 2005. PMID: 16103787 Review.
Hyporesponsiveness to erythropoietin: causes and management.
Elliott J, Mishler D, Agarwal R. Elliott J, et al. Among authors: agarwal r. Adv Chronic Kidney Dis. 2009 Mar;16(2):94-100. doi: 10.1053/j.ackd.2008.12.004. Adv Chronic Kidney Dis. 2009. PMID: 19233068 Review.
Subgroup analyses in nephrology clinical trials.
Fishbane S, Shah HH, Kataria A, Shirazian S, Agarwal R. Fishbane S, et al. Among authors: agarwal r. Clin J Am Soc Nephrol. 2012 Nov;7(11):1872-6. doi: 10.2215/CJN.04870512. Epub 2012 Jul 26. Clin J Am Soc Nephrol. 2012. PMID: 22837274 No abstract available.
Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON).
de Zeeuw D, Akizawa T, Agarwal R, Audhya P, Bakris GL, Chin M, Krauth M, Lambers Heerspink HJ, Meyer CJ, McMurray JJ, Parving HH, Pergola PE, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Warnock DG, Wittes J, Chertow GM. de Zeeuw D, et al. Among authors: agarwal r. Am J Nephrol. 2013;37(3):212-22. doi: 10.1159/000346948. Epub 2013 Feb 28. Am J Nephrol. 2013. PMID: 23467003 Free article. Clinical Trial.
Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators. de Zeeuw D, et al. N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9. N Engl J Med. 2013. PMID: 24206459 Free PMC article. Clinical Trial.
Thiazide Diuretics in Chronic Kidney Disease.
Sinha AD, Agarwal R. Sinha AD, et al. Among authors: agarwal r. Curr Hypertens Rep. 2015 Mar;17(3):13. doi: 10.1007/s11906-014-0525-x. Curr Hypertens Rep. 2015. PMID: 25749608 Review.
4,102 results